Management ChangeJun 15, 2026, 04:17 PM
Immuneering Appoints Andrew Gengos as CFO; Base Salary $530,000
AI Summary
Immuneering Corp. has appointed Andrew Gengos as its new Chief Financial Officer and Treasurer, effective on or before July 16, 2026. Mr. Gengos brings extensive financial and strategic leadership experience from various biopharmaceutical companies, including Terns Pharmaceuticals and Amgen Inc. He will receive an annual base salary of $530,000, a target annual bonus of 40% of his base salary, and an inducement option to purchase 650,000 shares. Mallory Morales will continue as Senior Vice President Finance and Chief Accounting Officer.
Key Highlights
- Andrew Gengos appointed Chief Financial Officer and Treasurer, effective by July 16, 2026.
- Mr. Gengos previously served as CFO at Terns Pharmaceuticals and LeonaBio Inc.
- Annual base salary set at $530,000.
- Eligible for a target annual performance bonus of 40% of base salary.
- Granted an option to purchase 650,000 shares of common stock.
- Mallory Morales continues as SVP Finance, Chief Accounting Officer.
- Severance includes 12 months base salary and 1.0x target bonus upon change in control.
Price Impact
More from IMRX